Published on

Medicine - Immunoglobulin A (IgA)

Immunoglobulin A (IgA) is the principal antibody involved in mucosal immunity, protecting the respiratory, gastrointestinal and genitourinary tracts against pathogens.

IgA is predominantly a monomer in serum and a dimer in mucosal secretions. Its major function is to prevent microorganisms from attaching to and penetrating mucosal epithelial surfaces.

Key Examination Associations
  • Serum IgA is predominantly monomeric.
  • Secretory IgA is predominantly dimeric.
  • Dimeric IgA contains a J chain.
  • Secretory IgA contains a secretory component.
  • IgA-producing plasma cells are abundant in mucosal tissues.
  • IgA is the principal antibody for mucosal immunity.
  • IgA does not efficiently activate classical complement.

1. Structure of IgA

A. Monomeric IgA

  • Predominantly found in serum.
  • Contains two alpha (α) heavy chains.
  • Contains two light chains.
  • Has two antigen-binding sites.

B. Dimeric IgA

  • Predominantly found in mucosal secretions.
  • Consists of two IgA monomers.
  • Joined by a J chain.
  • Has four potential antigen-binding sites.
  • Secretory IgA also contains a secretory component.

Comparison of IgA Forms

Feature Serum IgA Secretory IgA
Structure Monomer Dimer
J chain Usually absent Present
Secretory component Absent Present
Main location Blood Mucosal secretions
Main function Systemic immune functions Mucosal protection
Exam Point: IgA is a monomer in serum and predominantly a dimer in mucosal secretions.

2. Production of IgA by MALT

IgA-producing plasma cells are especially abundant in mucosal tissues associated with mucosa-associated lymphoid tissue (MALT).

Important MALT Sites

  • GALT - Gut-associated lymphoid tissue.
  • BALT - Bronchus-associated lymphoid tissue.
  • NALT - Nasal-associated lymphoid tissue.
  • Tonsils and other mucosal lymphoid structures.

Mechanism of IgA Production

  1. Antigens enter mucosal surfaces.
  2. Mucosal antigen-presenting cells initiate immune responses.
  3. B cells undergo class switching to IgA.
  4. IgA-producing plasma cells develop in mucosal tissues.
  5. Dimeric IgA is secreted and transported across epithelial cells.
  6. Secretory IgA protects the mucosal surface.

Cytokines Involved

  • TGF-β: Major cytokine promoting IgA class switching.
  • IL-10 and IL-21: Can support IgA responses.
  • BAFF and APRIL: Contribute to IgA responses in appropriate settings.

3. Transport of Secretory IgA

Dimeric IgA is transported across epithelial cells by the polymeric immunoglobulin receptor (pIgR).

Visual Flowchart

Mucosal Plasma Cell Produces dimeric IgA with J chain IgA Binds pIgR Basolateral epithelial surface Transcytosis Transport through epithelial cell pIgR Cleavage Secretory component remains attached Secretory IgA Released Mucosal surface protection

Importance of the Secretory Component

  • Protects IgA against proteolytic degradation.
  • Supports stability in mucosal secretions.
  • Helps IgA persist within the mucus layer.
High-Yield Distinction: J chain joins IgA monomers. Secretory component helps protect secretory IgA against degradation.

4. Functions of IgA

A. Mucosal Immunity

IgA protects the:

  • Respiratory tract.
  • Gastrointestinal tract.
  • Genitourinary tract.
  • Oral cavity.

B. Neutralisation

IgA binds and neutralises:

  • Viruses.
  • Bacterial toxins.
  • Microbial antigens.

This reduces the ability of pathogens and toxins to interact with epithelial cells.

C. Immune Exclusion

  • Prevents microbial adherence to epithelial cells.
  • Promotes aggregation of microorganisms.
  • Helps trap pathogens in mucus.

D. Regulation of Mucosal Inflammation

Secretory IgA provides protection while generally limiting excessive inflammation.

This is particularly important in the intestine, where the immune system must coexist with commensal microorganisms and food antigens.

5. IgA and Complement Activation

IgA does not efficiently activate the classical complement pathway because it does not effectively bind C1q.

Under certain experimental or inflammatory conditions, IgA-containing complexes may promote alternative complement pathway activation or amplification.

Important Correction: Alternative complement activation is not a principal protective function of secretory IgA. Secretory IgA is generally relatively non-inflammatory. The alternative complement pathway can also activate without antibodies.

Complement Comparison

Immunoglobulin Complement Activity
IgM Strong classical pathway activation
IgG Classical pathway; subclass-dependent
IgA May promote alternative pathway activation in certain settings
IgE Does not normally activate complement
IgD Not a major complement activator

6. IgA in Breast Milk and Neonatal Immunity

Secretory IgA is abundant in colostrum and breast milk.

Functions:
  • Provides passive mucosal immunity.
  • Protects the infant gastrointestinal tract.
  • Neutralises microorganisms and toxins.
  • Reduces microbial attachment to intestinal cells.
  • Supports healthy interactions with intestinal microbes.
Exam Point: IgG crosses the placenta and provides systemic passive immunity. IgA is supplied through breast milk and provides mainly mucosal protection.

7. IgA Subclasses

IgA1

  • Predominant subclass in serum.
  • Common in upper respiratory secretions.
  • Has a relatively long hinge region.

IgA2

  • Relatively more abundant in distal intestinal secretions.
  • More resistant to certain bacterial IgA1 proteases.
  • Important in gastrointestinal mucosal immunity.

8. Clinical Associations

A. Selective IgA Deficiency

Selective IgA deficiency is one of the most common primary antibody deficiencies.

It is characterised by markedly reduced serum IgA with normal IgG and IgM, after appropriate evaluation in patients aged at least 4 years.

Possible clinical features:
  • Recurrent respiratory infections.
  • Recurrent gastrointestinal infections.
  • Giardiasis.
  • Allergic disorders.
  • Autoimmune diseases.

Many individuals remain asymptomatic.

A minority of patients with anti-IgA antibodies may develop severe reactions to certain blood products.

B. IgA Nephropathy

IgA nephropathy is characterised by IgA-containing immune complex deposition in the glomerular mesangium.

Clinical features:
  • Episodic haematuria.
  • Haematuria during or shortly after respiratory infection.
  • Proteinuria.
  • Hypertension.
  • Possible progressive kidney dysfunction.
Exam Point: IgA nephropathy is associated with synpharyngitic haematuria.

C. IgA Vasculitis

IgA vasculitis was previously known as Henoch-Schonlein purpura.

It is an IgA-associated small-vessel vasculitis, particularly affecting children.

Classical features:
  • Palpable purpura.
  • Arthralgia or arthritis.
  • Abdominal pain.
  • Renal involvement.

D. Coeliac Disease

IgA-based serological testing is commonly used in the investigation of coeliac disease.

Important investigations:
  • Tissue transglutaminase IgA (tTG-IgA).
  • Total serum IgA.

Total IgA is measured because selective IgA deficiency may produce falsely negative IgA-based coeliac serology.

9. Important Properties of IgA

  • Monomeric in serum.
  • Predominantly dimeric in secretions.
  • Contains alpha heavy chains.
  • Dimeric IgA contains a J chain.
  • Secretory IgA contains a secretory component.
  • Produced abundantly in mucosal tissues.
  • Principal antibody for mucosal immunity.
  • Neutralises pathogens and toxins.
  • Prevents microbial adherence.
  • Abundant in breast milk and colostrum.
  • Does not significantly cross the placenta.
  • Does not efficiently activate classical complement.
  • May participate in alternative complement activation under certain conditions.

10. Important Corrections

  1. Serum IgA is mainly monomeric; secretory IgA is mainly dimeric.
  2. Dimeric IgA contains a J chain.
  3. Secretory IgA additionally contains a secretory component.
  4. IgA-producing plasma cells are abundant in mucosal tissues associated with MALT.
  5. TGF-beta is a major cytokine promoting IgA class switching.
  6. IgA crosses epithelial cells through pIgR-mediated transcytosis.
  7. Its main functions are neutralisation and immune exclusion.
  8. IgA does not efficiently activate classical complement.
  9. Alternative complement activation may occur in certain conditions but is not its main mucosal function.
  10. Breast milk IgA provides passive mucosal protection.

11. High-Yield Examination Summary

Structure
  • Serum IgA: Monomer.
  • Secretory IgA: Dimer with J chain and secretory component.
Production
  • Mucosal plasma cells associated with MALT.
  • TGF-beta promotes IgA class switching.
Functions
  • Mucosal immunity.
  • Neutralisation of pathogens and toxins.
  • Prevention of microbial adherence.
Complement
  • Not an efficient classical pathway activator.
  • May promote alternative pathway activation in certain settings.
Clinical Associations
  • Selective IgA deficiency.
  • IgA nephropathy.
  • IgA vasculitis.
  • Coeliac disease serological testing.
Most Important Examination Point: IgA is the principal mucosal immunoglobulin. It is predominantly monomeric in serum and dimeric in secretions, and protects mucosal surfaces through neutralisation and immune exclusion.

Medicine - Immunology Revision Notes

Image description
0 Comments